deprexis

Trade name

deprexis

04260670630617

42606706365P

Reference / catalog number

6

GS1

Class I

Applicable legislation

MDR [Regulation (EU) 2017/745 on medical devices]

Status

On the market

Quantity

1

Additional product description

deprexis is intended to provide therapeutic methods and exercises based on evidence-based psychological and psychotherapeutic therapies for patients with unipolar depression or depressive disorders, to help them managing their depression or depressive disorder. deprexis is intended as a self-application supplemental to care-as-usual for patients 18 years of age or older. deprexis can be used for a period of 90 days. deprexis is neither intended to replace treatment provided by a health care provider nor to provide information which is used to take decisions with diagnosis or therapeutic purposes.

Additional information URL

https://deprexis.broca.io/en-US/help/50002984

Clinical sizes

No clinical sizes registered for this device.

European Medical Device Nomenclature — the EU product classification assigned to this device.

• V92MEDICAL DEVICE SOFTWARE - NOT INCLUDED IN OTHER CLASSES

1 warning recorded — scroll inside the panel to see all entries.

• CW999

  Contraindications: deprexis should not be used by patients with psychotic disorders (e.g. schizophrenia), bipolar disorders or by patients at risk of suicide. Explanation: A patient is considered at risk of suicide if they have harboured serious intent to commit suicide during the past 90 days (regardless of whether there was a concrete plan to do so). Patients who have attempted suicide during the past 12 months are also considered at risk.